Since RIPK1 was recently shown to regulate cellular responses to DNA damage26, we hypothesized that CYLD might control DNA damage-induced cell death and tumour development by regulating RIP kinase-dependent pathways and tested this hypothesis using relevant genetic mouse models. Here, RIPK1 is linked to neoplasm.